최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Pharmaceuticals, v.15 no.5, 2022년, pp.619 -
Ochnik, Michał (Laboratory of Virology, Department of Immunology of Infectious Diseases, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland) , Franz, Dominika (michal.ochnik@hirszfeld.pl (M.O.)) , Sobczyński, Maciej (dominika.franz@hirszfeld.pl (D.F.)) , Naporowski, Piotr (beata.orzechowska@hirszfeld.pl (B.O.)) , Banach, Mariusz (Laboratory of Virology, Department of Immunology of Infectious Diseases, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, 53-114 Wroclaw, Poland) , Orzechowska, Beata (michal.ochnik@hirszfeld.pl (M.O.)) , Sochocka, Marta (dominika.franz@hirszfeld.pl (D.F.))
Viral and bacterial diseases are among the greatest concerns of humankind since ancient times. Despite tremendous pharmacological progress, there is still a need to search for new drugs that could treat or support the healing processes. A rich source of bioactive compounds with antiviral potency inc...
1. Paules C. Subbarao K. Influenza Lancet 2017 390 697 708 10.1016/S0140-6736(17)30129-0 28302313
2. Mostafa A. Abdelwhab E.M. Mettenleiter T.C. Pleschka S. Zoonotic Potential of Influenza A Viruses: A Comprehensive Overview Viruses 2018 10 497 10.3390/v10090497 30217093
3. Krammer F. Smith G.J.D. Fouchier R.A.M. Peiris M. Kedzierska K. Doherty P.C. Palese P. Shaw M.L. Treanor J. Webster R.G. Influenza Nat. Rev. Dis. Primers 2018 4 3 10.1038/s41572-018-0002-y 29955068
4. World Health Organization Influenza Available online: https://www.who.int/teams/health-product-policy-and-standards/standards-and-specifications/vaccines-quality/influenza (accessed on 31 August 2021)
5. De Clercq E. Li G. Approved Antiviral Drugs over the Past 50 Years Clin. Microbiol. Rev. 2016 29 695 747 10.1128/CMR.00102-15 27281742
6. Heo Y.-A. Baloxavir: First Global Approval Drugs 2018 78 693 697 10.1007/s40265-018-0899-1 29623652
7. FDA Influenza (Flu) Antiviral Drugs and Related Information 2020 Available online: https://www.fda.gov/drugs/information-drug-class/influenza-flu-antiviral-drugs-and-related-information (accessed on 4 September 2021)
8. European Medicines Agency Antiviral Medicines for Pandemic Influenza Available online: https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/pandemic-influenza/antiviral-medicines-pandemic-influenza (accessed on 4 September 2021)
9. Bai Y. Jones J. Wong S.-S. Zanin M. Antivirals Targeting the Surface Glycoproteins of Influenza Virus: Mechanisms of Action and Resistance Viruses 2021 13 624 10.3390/v13040624 33917376
10. Cui J. Li F. Shi Z.-L. Origin and evolution of pathogenic coronaviruses Nat. Rev. Microbiol. 2019 17 181 192 10.1038/s41579-018-0118-9 30531947
11. Chen B. Tian E.-K. He B. Tian L. Han R. Wang S. Xiang Q. Zhang S. El Arnaout T. Cheng W. Overview of lethal human coronaviruses Signal Transduct. Target. Ther. 2020 5 89 10.1038/s41392-020-0190-2 32533062
12. FDA Know Your Treatment Options for COVID-19 2021 Available online: https://www.fda.gov/consumers/consumer-updates/know-your-treatment-options-covid-19 (accessed on 26 September 2021)
13. Dimitrova E.K. European Medicines Agency Veklury 2020 Available online: https://www.ema.europa.eu/en/medicines/human/EPAR/veklury (accessed on 26 September 2021)
14. Beigel J.H. Tomashek K.M. Dodd L.E. Mehta A.K. Zingman B.S. Kalil A.C. Hohmann E. Chu H.Y. Luetkemeyer A. Kline S. Remdesivir for the Treatment of COVID-19—Preliminary report N. Engl. J. Med. 2020 383 1813 1826 10.1056/NEJMoa2007764 32445440
15. Ekor M. The growing use of herbal medicines: Issues relating to adverse reactions and challenges in monitoring safety Front. Pharmacol. 2014 4 177 10.3389/fphar.2013.00177 24454289
16. Richman D.D. Antiviral drug resistance Antivir. Res. 2006 71 117 121 10.1016/j.antiviral.2006.03.004 16621040
17. Shyr Z.A. Cheng Y.-S. Lo D.C. Zheng W. Drug combination therapy for emerging viral diseases Drug Discov. Today 2021 26 2367 2376 10.1016/j.drudis.2021.05.008 34023496
18. Denaro M. Smeriglio A. Barreca D. De Francesco C. Occhiuto C. Milano G. Trombetta D. Antiviral activity of plants and their isolated bioactive compounds: An update Phytother. Res. 2020 34 742 768 10.1002/ptr.6575 31858645
19. Porter R.S. Bode R.F. A Review of the Antiviral Properties of Black Elder ( Sambucus nigra L.) Products Phytother. Res. 2017 31 533 554 10.1002/ptr.5782 28198157
20. Młynarczyk K. Walkowiak-Tomczak D. Łysiak G.P. Bioactive properties of Sambucus nigra L. as a functional ingredient for food and pharmaceutical industry J. Funct. Foods 2018 40 377 390 10.1016/j.jff.2017.11.025 32362939
22. Jurikova T. Mlcek J. Skrovankova S. Sumczynski D. Sochor J. Hlavacova I. Snopek L. Orsavová J. Fruits of Black Chokeberry Aronia melanocarpa in the Prevention of Chronic Diseases Molecules 2017 22 944 10.3390/molecules22060944
23. Vlachojannis J.E. Cameron M. Chrubasik S. A systematic review on the sambuci fructus effect and efficacy profiles. Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives Phytother. Res. 2010 24 1 8 10.1002/ptr.2729 19548290
24. Zheng J. Chen F. Wu K. Wang J. Li F. Huang S. Lu J. Huang J. Liu H. Zhou R. Clinical and virological impact of single and dual infections with influenza A (H1N1) and SARS-CoV-2 in adult inpatients PLoS Negl. Trop. Dis. 2021 15 e0009997 10.1371/journal.pntd.0009997 34843492
25. Knox Y.M. Hayashi K. Suzutani T. Ogasawara M. Yoshida I. Shiina R. Tsukui A. Terahara N. Azuma M. Activity of anthocyanins from fruit extract of Ribes nigrum L. against influenza A and B viruses Acta Virol. 2001 45 209 215 11885927
26. Amoros M. Simõs C.M.O. Girre L. Sauvager F. Cormier M. Synergistic Effect of Flavones and Flavonols against Herpes Simplex Virus Type 1 in Cell Culture. Comparison with the Antiviral Activity of Propolis J. Nat. Prod. 1992 55 1732 1740 10.1021/np50090a003 1338212
27. Musarra-Pizzo M. Pennisi R. Ben-Amor I. Smeriglio A. Mandalari G. Sciortino M.T. In Vitro Anti-HSV-1 Activity of Polyphenol-Rich Extracts and Pure Polyphenol Compounds Derived from Pistachios Kernels ( Pistacia vera L.) Plants 2020 9 267 10.3390/plants9020267 32085514
28. Wallace L.E. Liu M. van Kuppeveld F.J. de Vries E. de Haan C.A. Respiratory mucus as a virus-host range determinant Trends Microbiol. 2021 29 983 992 10.1016/j.tim.2021.03.014 33875348
29. Swaminathan K. Dyason J.C. Maggioni A. von Itzstein M. Downard K.M. Binding of a natural anthocyanin inhibitor to influenza neuraminidase by mass spectrometry Anal. Bioanal. Chem. 2013 405 6563 6572 10.1007/s00216-013-7068-x 23748498
30. Kannan S. Kolandaivel P. The inhibitory performance of flavonoid cyanidin-3-sambubiocide against H274Y mutation in H1N1 influenza virus J. Biomol. Struct. Dyn. 2018 36 4255 4269 10.1080/07391102.2017.1413422 29199545
31. Ra J.-E. Seo K.H. Ko J.Y. Lee M.-J. Kang H.J. Kim S.L. Chung I.-M. Seo W.D. Antioxidative Effect and Neuraminidase Inhibitory Activity of Polyphenols Isolated from a New Korean Red Waxy Sorghum ( Sorghum bicolor L. cv. Hwanggeumchalsusu) J. Life Sci. 2015 25 786 794 10.5352/JLS.2015.25.7.786
32. Chojnacka K. Skrzypczak D. Izydorczyk G. Mikula K. Szopa D. Witek-Krowiak A. Antiviral Properties of Polyphenols from Plants Foods 2021 10 2277 10.3390/foods10102277 34681326
33. Pour P.M. Fakhri S. Asgary S. Farzaei M.H. Echeverría J. The Signaling Pathways, and Therapeutic Targets of Antiviral Agents: Focusing on the Antiviral Approaches and Clinical Perspectives of Anthocyanins in the Management of Viral Diseases Front. Pharmacol. 2019 10 1207 10.3389/fphar.2019.01207 31787892
34. Kim C.-H. Anti–SARS-CoV-2 Natural Products as Potentially Therapeutic Agents Front. Pharmacol. 2021 12 590509 10.3389/fphar.2021.590509 34122058
35. Marín L. Miguélez E.M. Villar C.J. Lombó F. Bioavailability of Dietary Polyphenols and Gut Microbiota Metabolism: Antimicrobial Properties BioMed. Res. Int. 2015 2015 905215 10.1155/2015/905215 25802870
36. González-Barrio R. Borges G. Mullen W. Crozier A. Bioavailability of Anthocyanins and Ellagitannins Following Consumption of Raspberries by Healthy Humans and Subjects with an Ileostomy J. Agric. Food Chem. 2010 58 3933 3939 10.1021/jf100315d 20218618
37. Cao G. Muccitelli H.U. Sanchez-Moreno C. Prior R.L. Anthocyanins are absorbed in glycated forms in elderly women: A pharmacokinetic study Am. J. Clin. Nutr. 2001 73 920 926 10.1093/ajcn/73.5.920 11333846
38. Wu X. Cao G. Prior R.L. Absorption and Metabolism of Anthocyanins in Elderly Women after Consumption of Elderberry or Blueberry J. Nutr. 2002 132 1865 1871 10.1093/jn/132.7.1865 12097661
39. Manach C. Williamson G. Morand C. Scalbert A. Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies Am. J. Clin. Nutr. 2005 81 230S 242S 10.1093/ajcn/81.1.230S 15640486
40. Roschek B. Jr. Fink R. McMichael M.D. Li D. Alberte R.S. Elderberry flavonoids bind to and prevent H1N1 infection in vitro Phytochemistry 2009 70 1255 1261 10.1016/j.phytochem.2009.06.003 19682714
41. Zhou J. Yuan X. Li L. Zhang T. Wang B. Comparison of different methods for extraction of Cinnamomi ramulus: Yield, chemical composition and in vitro antiviral activities Nat. Prod. Res. 2017 31 2909 2913 10.1080/14786419.2017.1299724 28322072
42. Krawitz C. Abu Mraheil M. Stein M. Imirzalioglu C. Domann E. Pleschka S. Hain T. Inhibitory activity of a standardized elderberry liquid extract against clinically-relevant human respiratory bacterial pathogens and influenza A and B viruses BMC Complement. Altern. Med. 2011 11 16 10.1186/1472-6882-11-16 21352539
43. Kinoshita E. Hayashi K. Katayama H. Hayashi T. Obata A. Anti-Influenza Virus Effects of Elderberry Juice and Its Fractions Biosci. Biotechnol. Biochem. 2012 76 1633 1638 10.1271/bbb.120112 22972323
44. Park S. Kim J.I. Lee I. Lee S. Hwang M.-W. Bae J.-Y. Heo J. Kim D. Han S.-Z. Park M.-S. Aronia melanocarpa and its components demonstrate antiviral activity against influenza viruses Biochem. Biophys. Res. Commun. 2013 440 14 19 10.1016/j.bbrc.2013.08.090 24012672
45. Ramakrishnan M.A. Determination of 50% endpoint titer using a simple formula World J. Virol. 2016 5 85 86 10.5501/wjv.v5.i2.85 27175354
46. da Silva R.F.R. Barreira J.C.M. Heleno S.A. Barros L. Calhelha R.C. Ferreira I.C.F.R. Anthocyanin Profile of Elderberry Juice: A Natural-Based Bioactive Colouring Ingredient with Potential Food Application Molecules 2019 24 2359 10.3390/molecules24132359
47. Lee J. Finn C.E. Anthocyanins and other polyphenolics in American elderberry ( Sambucus canadensis ) and European elderberry ( S. nigra ) cultivars J. Sci. Food Agric. 2007 87 2665 2675 10.1002/jsfa.3029 20836175
48. Zielińska A. Siudem P. Paradowska K. Gralec M. Kaźmierski S. Wawer I. Aronia melanocarpa Fruits as a Rich Dietary Source of Chlorogenic Acids and Anthocyanins: 1H-NMR, HPLC-DAD, and Chemometric Studies Molecules 2020 25 3234 10.3390/molecules25143234 32679898
49. Wu X. Gu L. Prior R.L. McKay S. Characterization of anthocyanins and proanthocyanidins in some cultivars of Ribes, Aronia, and Sambucus and their antioxidant capacity J. Agric. Food Chem. 2004 52 7846 7856 10.1021/jf0486850 15612766
51. Sochocka M. Sobczyński M. Ochnik M. Zwolińska K. Leszek J. Hampering Herpesviruses HHV-1 and HHV-2 Infection by Extract of Ginkgo biloba (EGb) and Its Phytochemical Constituents Front. Microbiol. 2019 10 2367 10.3389/fmicb.2019.02367 31681227
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.